3 not yet recruiting, 2 completed, 1 recruiting, 1 terminated. 8 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 8 | Not yet recruiting 3, Completed 2, Recruiting 1, Terminated 1, Unknown 1 |
Follow Population Groups: new trials by email Literature Review of Population Groups trials Research Report on Population Groups
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle Dexmedetomidine, Control (placebo) group - Sleep, Delirium | Early Phase 1 | Not yet recruiting | University of Alberta | 50 | 2026-12-01 | 2026-10-13 |
| Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules VV913 4mg group, VV913 8mg group, VV913 15mg group - Healthy Volunteers | Early Phase 1 | Recruiting | Vigonvita Life Sciences | 24 | 2026-04-13 | 2026-07-14 |
| A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects. Test drug XTYW007 capsules and placebo,Single dose group, Test drug XTYW007 capsules and placebo,Food Impact Group, Test drug XTYW007 capsules and placebo,Multiple dosing group - Non-Alcoholic Fatty Liver Disease | Early Phase 1 | Not yet recruiting | Xi'an Xintong Pharmaceutical Research Co.,Ltd. | 94 | 2026-03-25 | 2026-02-12 |
| Chronic Intervention With Sulforaphane-Smart® in Overweight and Obese Adults Sulforaphan-Smart® formula, Control (placebo) group - Obesity and Overweight | Early Phase 1 | Not yet recruiting | Mª Jesús Periago | 40 | 2025-07-01 | 2025-05-09 |
| Effect of Two Different Doses of Intrathecal Dexmedetomidine as Adjuvant in Elderly Patients Undergoing HoLEP Dexmedetomidine - Transurethral Resection of Prostate | Early Phase 1 | Completed | Mansoura University | 70 | 2022-05-30 | 2025-05-09 |
| Effects of Buspirone Combined With Clozapine Control group (clozapine, placebo), Low-dose group (buspirone tablets, clozapine), High-dose group (buspirone tablets, clozapine) - Schizophrenia | Early Phase 1 | Completed | Chuanfu Song | 46 | 2022-05-01 | 2025-04-02 |
| B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma Biological/Vaccine: Low-dose group, Biological/Vaccine: Mid-dose group, Biological/Vaccine: High-dose group - Advanced Hepatocellular Carcinoma | Early Phase 1 | Unknown | Tongji University | 3 | 2021-10-29 | 2023-12-15 |
| Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas topical 0.5% Timolol, Control (placebo) group - Hemangioma, Infant | Early Phase 1 | Terminated | Oregon Health and Science University | 6 | 2010-03-01 | 2017-07-05 |
Critical Illness (1) · Delirium (1) · Hemangioma (1) · Hemangioma, Capillary (1) · Inflammation (1) · Non-alcoholic Fatty Liver Disease (1) · Obesity (1) · Overweight (1) · Schizophrenia (1)
Chuanfu Song (1) · Mansoura University (1) · Mª Jesús Periago (1) · Oregon Health and Science University (1) · Tongji University (1) · University of Alberta (1) · Vigonvita Life Sciences (1) · Xi'an Xintong Pharmaceutical Research Co.,Ltd. (1)
China (4) · Egypt (1) · Spain (1) · United States (1)
Alfons L. Krol, M.D. (1) · Huan Zhou (1) · Mahmoud M Othman, MD (1) · Qing Xu (1) · Taha R Elashmawy, BCH (1)